Carfilzomib, a proteasome inhibitor, is present in Carfilnat 60Mg Inj. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.

FAQs

How does Carfilnat 60Mg Inj work?

Carfilnat 60Mg Inj contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.

Is it safe to father a child while taking Carfilnat 60Mg Inj?

No, it is unsafe to father a child while taking Carfilnat 60Mg Inj. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Carfilnat 60Mg Inj.

Is Carfilnat 60Mg Inj combines with other medications to treat multiple myeloma?

Based on the medical condition, Carfilnat 60Mg Inj may be given alone or together with other medicines used to treat multiple myeloma.

What should I do if I experience Infusion-related reactions?

Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.

Carfilnat 60Mg Inj causes a drop in blood cell count?

Carfilnat 60Mg Inj can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.